is a breakthrough precision immunotherapy that trains your immune system with unprecedented specificity using dendritic cell science. Our Phase III clinical protocol is now active across 42 global locations, with proven results in improving patient outcomes.
Patients treated in Phase III clinical trials with 3.2× survival improvement.
94% immune activation rate. Unprecedented specificity. Dendritic cell science reimagined for modern oncology with <0.5% severe adverse events.
Schedule a ConsultationOur center uses the latest in genomic sequencing, AI-assisted diagnostics, robotic surgery, and proton therapy to ensure each patient receives the most effective, least invasive treatment possible.
+702-817-9744Browse our oncologists
Pick your preferred time
Start your care journey
Your information will be forwarded to our oncology scheduling team who will contact you within 24 hours to confirm your appointment.